JavaScript is disabled. Please enable to continue!

Mobile search icon
More Resources >> Our People >> J. David Legan

J. David Legan

Sidebar Image
J. David Legan, PhD

J. David Legan, PhD

Director of Science

David earned his Ph.D. in Food Technology from the University of Reading in the UK by modeling the ecology of mixed microbial populations, and then moved to Campden BRI in a variety of microbiological food safety research and client service roles. During that time, he was project lead for the Bacillus component of the UK’s pathogen modeling program.  He moved again to Nabisco Research in New Jersey where he ran the corporate microbiology lab and developed a program of preservation technology development and microbial modeling.  After the Kraft Foods acquisition, he moved to Chicago to work on Food Safety and Preservation research, and through modeling and validation studies:

  • Optimized Oscar Mayer’s use of lactate and diacetate and their naturally cultured alternatives as Listeria-control agents in Ready to Eat meats
  • Specified process conditions central to Oscar Mayer’s commercial launch of High Pressure Pasteurization of naturally cured RTE meats

David had responsibility for the Kraft cultures R&D group, developed a partnership to explore microwave sterilization leading to several patents, and led a program that developed an internal proprietary natural antimicrobial commercialized in several Kraft products. Technologies from his group supported approximately $4 billion in annual sales.

After years as a microbiology "client", he is now back in the "provider" role as Director of Science at Eurofins Microbiology Laboratories, Inc., by way of the Covance Food Solutions group based in Madison, WI, which he joined in 2016.  In this role, he ensures appropriate method validation, explores new testing technologies, and fields multiple complicated food microbiology questions.

Products that his team has evaluated or developed and launched include:

  • The 3M MDS platform in the Madison microbiology laboratory
  • Flow cytometry for enumeration of probiotics
  • Strain-level confirmation of probiotic identification using the polymerase chain reaction (PCR)
  • Next-generation sequencing using the Oxford Nanopore Technologies GridION sequencing platform for microbial identification and microbiome analysis

 

Below are resources from David:



Eurofins GeneScan is pleased to announce the promotion of Frank Spiegelhalter to the position of Chief Scientific Officer (CSO) for Allergens and GMO Testing. In this new role, Frank will lead GeneScan's efforts in advancing allergen and GMO testing capabilities, continuing the tradition of innovation and excellence that the company is renowned for.


The regulations and requirements surrounding bioengineered foods are confusing, especially when navigating federal regulations and the voluntary non-GMO Project verification. This FAQ answers common questions surrounding the National Bioengineered Food Disclosure Standard, the non-GMO Project, and testing options at Eurofins.


This webinar will provide insights on how a manufacturer validates Bioengineered removal processes and verify compliance with the rule. Original airdate September 15, 2022.


The USDA establishes a new standard for disclosing bioengineered food. Does the mandate apply to you? Read to learn more.


Food and supplement industry trends show consumers’ want more transparency. Learn more about what consumers are interested in and how working with a transparent third party lab can help you build a more trustworthy brand.


In this digital conference Eurofins experts, industry partners and food safety thought leaders guide attendees through a discussion of the latest solutions and controls for persistent pet food manufacturing issues.


Discover the strategies for GMO testing and how Eurofins GeneScan can help you with any testing needs.



https://www.eurofinsus.com/food-testing